Trial Review

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12618000129280
Ethics application status
Approved
Date submitted
22/11/2017
Date registered
30/01/2018
Date last updated
30/01/2018
Type of registration
Retrospectively registered

Titles & IDs
Public title
In patients receiving regional anaesthesia of the arm for arteriovenous(AV) fistula surgery, can washout with normal saline increase the speed of resolution of the block after the surgery has been completed.
Scientific title
Reversing the effects of peripheral nerve block in patients undergoing AV fistula surgery using normal saline to "wash off" the block with 10mL of saline every 15 minutes following the surgery speed the offset of the block in terms of return of motor and sensory function.
Secondary ID [1] 293424 0
None
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Regional anaesthesia 305581 0
Condition category
Condition code
Anaesthesiology 304811 304811 0 0
Anaesthetics

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Following completion of AV fistula surgery the patient is transferred to the recovery room. Here a recovery nurse will flush 10ml of normal saline down the peripheral nerve catheter every 15 minutes for one hour, in the intervention group, and the control group has nothing done to the catheter. A blinded observer then assesses the patients block, 4 times during the hour that the patient stays in recovery. They assess the motor and sensory function in the 4 major nerves of the arm, and assess the pain scores of the patient.
Intervention code [1] 299666 0
Treatment: Other
Comparator / control treatment
Control group has a peripheral nerve catheter, but no washout.
Control group
Active

Outcomes
Primary outcome [1] 304021 0
Motor function is assessed with movements controlled by the 4 major nerves and graded on Bromage score of 0 to 5 depending on the strength of the movement.
Timepoint [1] 304021 0
There are 4 assessments of the patients block during their time in recovery. These are timed to be 5 minutes after the intervention (normal saline flush), in the intervention group and at the same time in the control group. This means the block is assessed when the patient first reaches recovery and then every 15 minutes for one hour.
Primary outcome [2] 304318 0
Sensory function of the forearm in terms of light touch and temperature sensation in the 4 nerve territories of the arm.
Timepoint [2] 304318 0
Every 15 minutes for 1 hour.
Primary outcome [3] 304319 0
Pain scores self reported by the patient on scale of 1-10.
Timepoint [3] 304319 0
Every 15 minutes for one hour.
Secondary outcome [1] 341572 0
None
Timepoint [1] 341572 0
None

Eligibility
Key inclusion criteria
• Provide informed written consent
• Adult (18 years or older) patients
• Having AV fistula formation under brachial plexus block
The patients block is measured on first admission to recovery room, and then every 15 minutes for one hour while in the recovery room. AV fistula patients are routinely discharged home after one hour in recovery.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
• Failure to provide informed consent
• Infection at the needle insertion site
• Known coagulopathy
• Known allergy to local anesthetics
• Presence of sensory or motor impairment in the distribution of the brachial plexus prior to nerve blockade
• Inability to perform valid sensory or motor assessment due to impaired access to the limb, language barrier, or inability of the subject to co-operate with such examination

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
20 patients will be allocated to each group, so 40 slips of paper containing the group allocation will be placed into envelopes that will be drawn randomly from a box when a patient is recruited into the study.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Randomly drawn envelope.
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?


The people assessing the outcomes
Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis
Data will be recorded on a data sheet and transferred to an Excel spreadsheet for statistical analysis. Comparisons between groups will be performed with Student’s t-test. Qualitative data will be reported as either absolute numbers or percentage and will be analyzed by Chi-square analysis or Fisher’s exact test, whichever is appropriate. A p value of < 0.05 will be considered statistically significant.

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
Actual
10/11/2014
Date of last participant enrolment
Anticipated
Actual
20/01/2016
Date of last data collection
Anticipated
Actual
20/01/2016
Sample size
Target
40
Accrual to date
Final
37
Recruitment outside Australia
Country [1] 9390 0
New Zealand
State/province [1] 9390 0
Waikato

Funding & Sponsors
Funding source category [1] 298049 0
Hospital
Name [1] 298049 0
Waikato hospital
Country [1] 298049 0
New Zealand
Primary sponsor type
Hospital
Name
Waikato hospital
Address
Pembroke Street
Hamilton 3200
Country
New Zealand
Secondary sponsor category [1] 297123 0
None
Name [1] 297123 0
Nil
Address [1] 297123 0
Nil
Country [1] 297123 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 299071 0
Northern B Ethics committee
Ethics committee address [1] 299071 0
Ethics committee country [1] 299071 0
New Zealand
Date submitted for ethics approval [1] 299071 0
15/03/2014
Approval date [1] 299071 0
01/05/2014
Ethics approval number [1] 299071 0
14/NTB/45

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 79194 0
Dr Kelly Byrne
Address 79194 0
Dept. of Anaesthesia
Waikato hospital
Pembroke Street
Hamilton 3200
New Zealand
Country 79194 0
New Zealand
Phone 79194 0
+642102224390
Fax 79194 0
Email 79194 0
[email protected]
Contact person for public queries
Name 79195 0
Kelly Byrne
Address 79195 0
Dept. of Anaesthesia
Waikato hospital
Pembroke Street
Hamilton 3200
New Zealand
Country 79195 0
New Zealand
Phone 79195 0
+642102224390
Fax 79195 0
Email 79195 0
[email protected]
Contact person for scientific queries
Name 79196 0
Kelly Byrne
Address 79196 0
Dept. of Anaesthesia
Waikato hospital
Pembroke Street
Hamilton 3200
New Zealand
Country 79196 0
New Zealand
Phone 79196 0
+642102224390
Fax 79196 0
Email 79196 0
[email protected]

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
TypeIs Peer Reviewed?DOICitations or Other DetailsAttachment
Plain language summaryNo No difference between the groups
Study results articleYes Reversing the Effects of a Peripheral Nerve Block ... [More Details] 374034-(Uploaded-15-05-2020-09-23-42)-Journal results publication.pdf

Documents added automatically
SourceTitleYear of PublicationDOI
Dimensions AIReversing the Effects of a Peripheral Nerve Block with Normal Saline: A Randomised Controlled Trial2020https://doi.org/10.5152/tjar.2019.09076
N.B. These documents automatically identified may not have been verified by the study sponsor.